Edition:
United Kingdom

DBV Technologies SA (DBV.PA)

DBV.PA on Paris Stock Exchange

12.42EUR
18 Jan 2019
Change (% chg)

€-0.16 (-1.27%)
Prev Close
€12.58
Open
€12.67
Day's High
€12.90
Day's Low
€12.37
Volume
272,449
Avg. Vol
268,594
52-wk High
€47.38
52-wk Low
€7.59

Chart for

About

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to... (more)

Overall

Beta: 0.44
Market Cap(Mil.): €1,956.98
Shares Outstanding(Mil.): 24.10
Dividend: --
Yield (%): --

Financials

  DBV.PA Industry Sector
P/E (TTM): -- 30.48 33.71
EPS (TTM): -5.32 -- --
ROI: -54.08 14.98 14.48
ROE: -57.09 16.31 15.99

Earnings vs. Estimates